Guided Therapeutics, Inc.’ LuViva® Advanced Cervical Scan Cited as Promising Solution to Reduce Unnecessary, Painful and Costly Procedures in European Healthcare Settings

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

LONDON--(BUSINESS WIRE)--Up to 40 percent of women currently undergoing unnecessary procedures for cervical disease diagnosis could avoid the psychological and financial burdens and the potential for medical complications from treatment if given a non-invasive test with the LuViva® Advanced Cervical Scan, according to an article appearing in the Hospital Healthcare Europe 2013 Bulletin journal (page 115). According to the article, in addition to an emotional impact, women undergoing additional testing after a suspicious Pap test reported physical effects of the unnecessary testing that included moderate to severe pain, moderate to severe bleeding and changes in their first menstrual period post colposcopy and biopsy.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC